Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD Fills Regulatory “Void” In Setting Advertising Standards

This article was originally published in The Tan Sheet

Executive Summary

NAD decisions reference FDA and Federal Trade Commission regulations while establishing standards for advertising claims, says senior attorney Kathleen Dunnigan. “What we really do is we fill a void which is to set advertising standards and to try to get truthful and accurate claims,” she says at FDLI’s annual conference.

Advertisement

Related Content

J&J Fights NAD Neutrogena Decision Assailing Sunscreen “Barrier”

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106865

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel